Melissa Thomas

Title: Innovations by Melissa Thomas in Immunotherapy

Introduction

Melissa Thomas is an accomplished inventor based in Palo Alto, CA. She has made significant contributions to the field of immunotherapy, particularly through her innovative work on chimeric receptors. Her research focuses on the development of antigen binding molecules and engineered immune cells that target the DLL3 antigen.

Latest Patents

Melissa holds a patent for "Chimeric receptors to DLL3 and methods of use thereof." This patent encompasses various aspects of antigen binding molecules, chimeric receptors, and engineered immune cells designed to interact with DLL3. The invention also includes vectors, compositions, and methods for treatment and detection utilizing these DLL3-targeting molecules.

Career Highlights

Melissa is currently employed at Amgen Inc., a leading biotechnology company known for its innovative therapies. Her work at Amgen has allowed her to collaborate with other talented professionals in the field, enhancing the impact of her research.

Collaborations

Some of her notable coworkers include Michael John Giffin and Christopher Murawsky. Their collaborative efforts contribute to the advancement of immunotherapy and the development of new treatment options.

Conclusion

Melissa Thomas is a pioneering inventor whose work in immunotherapy is paving the way for new therapeutic approaches. Her patent on DLL3-targeting chimeric receptors exemplifies her commitment to advancing medical science.